Position in IMVT
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$45,521,343
+$23,322,383 QoQ
Shares Held
1,181,452
+32.2% QoQ
Ownership
0.572%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#24
of 226 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 91%
Shared 0%
None 9%
Common Shares in IMVT Over Time
Shares Held
Position Value (USD)
Derivatives in IMVT
reported options exposure · as of Mar 31, 2024CallValue
$122,778
CallShares
3,800
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026BANK OF AMERICA CORP /DE/ holds $10,144,297,346 across 338 Biotechnology names. IMVT ranks #52 (0.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
3,039,178 | $1,509,650,884 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,291,053 | $805,023,185 | |
| 3 | CYTK |
Cytokinetics Inc
|
4,635,709 | $394,916,048 | |
| 4 | ARGX |
Argenx SE
|
400,234 | $371,325,094 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
994,476 | $299,367,107 | |
| 6 | JAZZ |
Jazz Pharmaceuticals plc
|
1,136,091 | $273,763,844 | |
| 7 | TVTX |
Travere Therapeutics, Inc.
|
4,568,341 | $259,527,450 | |
| 8 | RPRX |
Royalty Pharma plc
|
4,149,422 | $232,658,090 |
All Filings in IMVT
Export CSV
28 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $45,521,343 | 1,181,452 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $22,198,960 | 893,678 | Shares | Defined | 2026-05-18 | |
| 2025-12-31 | $7,968,684 | 313,481 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $6,041,274 | 374,769 | Shares | Defined | 2026-02-03 | |
| 2025-06-30 | $6,747,616 | 421,726 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $8,065,812 | 471,961 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $8,459,819 | 341,535 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $6,472,452 | 227,024 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $6,424,015 | 243,334 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $122,778 | 3,800 | Call | Defined | 2024-05-15 | |
| 2024-03-31 | $6,740,834 | 208,630 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $160,094 | 3,800 | Call | Defined | 2024-02-14 | |
| 2023-12-31 | $9,368,699 | 222,376 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $23,141,182 | 602,792 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $3,355,032 | 176,860 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $6,356,213 | 409,814 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $4,167,752 | 234,803 | Shares | Defined | 2023-02-10 | |
| 2022-09-30 | $142,132 | 25,472 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $56,252 | 14,424 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $144,178 | 26,167 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $1,920,816 | 225,448 | Shares | Defined | 2022-02-08 | |
| 2021-09-30 | $828,207 | 95,306 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $1,423,999 | 134,721 | Shares | Defined | 2021-09-13 | |
| 2021-03-31 | $1,993,658 | 124,293 | Shares | Defined | 2021-05-14 | |
| 2020-12-31 | $1,241,031 | 26,868 | Shares | Defined | 2021-02-10 | |
| 2020-09-30 | $1,177,104 | 33,450 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $292,126 | 11,997 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $130,932 | 8,412 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||